Processa Pharmaceuticals’ $6.25 Million Common Stock Offering

Foley & Lardner represented Processa Pharmaceuticals, while Sichenzia Ross Ference represented Spartan Capital Securities in the offering.Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), a diversified clinical-stage company developing…

This content is for Standard 1 Year members only.
Login Join Now
Laura Testa

Author: Laura Testa

This content is for Standard 1 Year members only.
Login Join Now